Advertisement

Topics

AmpliPhi Biosciences Corporation and The Westmead Institute Company Profile

23:44 EDT 18th June 2019 | BioPortfolio


News Articles [1412 Associated News Articles listed on BioPortfolio]

AmpliPhi, C3J reverse merge

AmpliPhi Biosciences Corp. is reverse merging with fellow infectious disease-focused firm C3J Therapeutics Inc. in a stock swap.

Researchers standardise test for predicting transplant rejection

(Westmead Institute for Medical Research) Researchers from The Westmead Institute for Medical Research have developed a standardised method of measuring the immune response in islet transplant recipie...

New Research Uncovers How Life-Threatening Fungal Diseases Adapt to Survive in Humans

NewsA new study from The Westmead Institute for Medical Research has uncovered how serious fungal infections grow in humans by conserving phosphate.

New study identifies genetic variant that could help reduce need for liver transplants

(Westmead Institute for Medical Research) A new study from the Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C...

AmpliPhi Biosciences Corp. (APHB) CEO Paul Grint on C3J Therapeutics Merger Conference Call (Transcript)

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

Shares of the combined company to commence trading on the NYSE American exchange under the new symbol “ARMP” on May 10, 2019 Completed $10 million concurrent financing Ongoing collaboratio...

AmpliPhi: Advancing Bacteriophage For The Treatment Of Bacterial Infections

AmpliPhi Biosciences (NYSEMKT: APHB) is a biotechnology company focused on the development of a pipeline of naturally occurring viruses called bacteriophages, the natural predators of bacteria. Phages...

$APHB and C3J Therapeutics Agree to Merge https://www.businesswire.com/news/home/20190104005257/en/AmpliPhi-Biosciences-C3J-Therapeutics-Agree-Merge …

$APHB and C3J Therapeutics Agree to Merge https://www.businesswire.com/news/home/20190104005257/en/AmpliPhi-Biosciences-C3J-Therapeutics-Agree-Merge …

Clinical Trials [735 Associated Clinical Trials listed on BioPortfolio]

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-PA01, for patients with serious or immediately life-threatening Pseudom...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Postmenopausal Estrogen/Progestin Interventions (PEPI)

To assess the effects of various postmenopausal estrogen replacement therapies on selected cardiovascular risk factors, including high density lipoprotein cholesterol, systolic blood press...

Companies [1766 Associated Companies listed on BioPortfolio]

AmpliPhi Biosciences Corporation and The Westmead Institute

AmpliPhi BioSciences Corporation

AmpliPhi Biosciences Corporation (AmpliPhi) is a biotechnology company dedicated to the development of innovative antibacterial solutions to improve human health through the application of its propr...

AmpliPhi BioSciences Corp.

AmpliPhi BioSciences Corp. is a biotechnology company focused on the development and commercialization of novel bacteriophage-based therapeutics for difficult to treat infectious ...

AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Corporation is a biotechnology company dedicated to the development of innovative anti-bacterial solutions to improve human health through the application of ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

More Information about "AmpliPhi Biosciences Corporation and The Westmead Institute" on BioPortfolio

We have published hundreds of AmpliPhi Biosciences Corporation and The Westmead Institute news stories on BioPortfolio along with dozens of AmpliPhi Biosciences Corporation and The Westmead Institute Clinical Trials and PubMed Articles about AmpliPhi Biosciences Corporation and The Westmead Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AmpliPhi Biosciences Corporation and The Westmead Institute Companies in our database. You can also find out about relevant AmpliPhi Biosciences Corporation and The Westmead Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record